GlucoStabilizer
Features Clinical Evidence About Blog Support
Request a Demo
FeaturesClinical EvidenceAboutBlogSupport
GlucoStabilizer
Request a Demo

Evaluation of a Computerized Insulin Dosing Tool for the Treatment of Diabetic Ketoacidosis

 

Kaleida Health | Journal of Pharmacy Practice

GlucoStabilizer is efficacious and safe for treatment of patients with a primary diagnosis of DKA when compared to provider-driven insulin dosing.

Click below to download.

Download ↓
 
Clinical EvidenceKnapsackDecember 2, 2020
Facebook0 Twitter Pinterest0 0 Likes
Previous

Evaluating The Safety and Efficacy of Glucostabilizer in the Management of Diabetic Ketoacidosis

Clinical EvidenceKnapsackDecember 2, 2020
Next

Software-guided Insulin Dosing Improves Intrapartum Glycemic Management in Women With Diabetes Mellitus

Clinical EvidenceKnapsackDecember 1, 2020
 
GlucoStabilizer (logo) an insulin management software for hospitals.
 
FeaturesClinical Evidence AboutBlogSupportRequest a Demo

© 2021 GlucoStabilizer®. All rights reserved. Site by Knapsack.